Certara is dedicated to improving human health through a broad spectrum of software products and services, from molecular discovery through clinical research, with special focus on supporting translational approaches to drug development. Certara’s operating divisions include Pharsight, which provides software and scientific services to improve productivity and decision-making in clinical drug development, and Tripos, which provides innovative scientific software solutions and services enabling life science researchers to improve the efficiency of molecular discovery.
Specialties
translational science software, scientific informatics
Certara Activity on LinkedIn
-
Certara has a new Business Development Director
Thomas Henry is now Business Development Director
